Posted Jun 10, 2025 at 4:29 PM EDT 2 Comments / 2 New A Twitter Andrew J. Hawkins A real Tesla robotaxi spotted in Austin. A Tesla Model Y with no one behind the steering wheel was spotted driving through Austin recently, according to a video posted to X and noticed by InsideEVs. The video was also reposted by Tesla's head of autonomy, Ashok Elluswamy, who wrote 'Slowly slowly at first, then …' seemingly confirming its authenticity. The Model Y also has 'Robotaxi' written in Tesla's notoriously difficult-to-read Cybertruck font on the passenger door. Bloomberg previously reported that the company's robotaxi service was set to launch this week on June 12th, though the automaker has yet to formally confirm the date.
A real Tesla robotaxi spotted in Austin.
A Tesla Model Y with no one behind the steering wheel was spotted driving through Austin recently, according to a video posted to X and noticed by InsideEVs. The video was also reposted by Tesla's head of autonomy, Ashok Elluswamy, who wrote 'Slowly slowly at first, then …' seemingly confirming its authenticity. The Model Y also has 'Robotaxi' written in Tesla's notoriously difficult-to-read Cybertruck font on the passenger door. Bloomberg previously reported that the company's robotaxi service was set to launch this week on June 12th, though the automaker has yet to formally confirm the date.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
26 minutes ago
- Bloomberg
Wayve CEO on London Self-Driving Cars Trial With Uber
Wayve Technologies CEO & Co-Founder Alex Kendall discusses the company's plans to remain "asset light" and adaptable for all car manufacturers. This comes after the startup's announcement earlier this week that they will be partnering with Uber to trial fully autonomous vehicles in London. The two companies have been working together for some time, with Uber owning a strategic investment in the London-based startup. Kendall speaks to Bloomberg's Tom Mackenzie at sidelines of Founders Forum in Oxfordshire, UK. (Source: Bloomberg)
Yahoo
35 minutes ago
- Yahoo
Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025
BOSTON, June 12, 2025 /PRNewswire/ -- Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the BIO International Convention 2025 (BIO 2025), taking place June 16-19 in Boston Convention & Exhibition Center. The company will exhibit at Booth #1851, presenting its differentiated pipeline, including the flagship Phase 1 immunocytokine FP008, a portfolio of promising early-stage candidates for oncology and autoimmune diseases, and its suite of proprietary technology platforms, while actively seeking global partnerships. FP008, Fapon Biopharma's lead asset, is a first-in-class immunocytokine currently in Phase 1 clinical trials, designed to address significant unmet needs in solid tumor patient refractory to anti-PD-1 therapy. The company will also feature promising preclinical candidates targeting oncology (FP010, FP011, FPE021) and autoimmune diseases (FPE022, FPE024), highlighting its expanding research capabilities. Fapon Biopharma will feature its proprietary and innovative technology platforms, engineered to overcome complex drug development challenges: Bi/Tri-TCE Platform: Human-monkey cross-reactive TCR/CD3 nanobody, enabling the design of potent multi-specific antibodies for targeted cancer immunotherapy. FILTEN™ (IL-10M Fusion Protein Platform): Overcoming IL-10 limitations for broad applications in cancer and autoimmune diseases PROTiNb™ (Proteolysis Targeting Intra-Nanobody): A pioneering platform targeting previously "undruggable" intracellular targets, demonstrating a strong competitive edge. FIND™ Mammalian Cell Display Platform: Accelerating antibody discovery by combining mammalian cell expression with high-throughput screening. "We are excited to connect with the global biopharma community at BIO 2025," said Vincent Huo, President of Fapon Biopharma. "We look forward to demonstrating the exciting progress of our internal pipeline and how our technology platforms can empower external partners to bring transformative therapy to patients faster." Engagement Opportunities:Exhibition Booth: #1851Company Presentation: Time: 11:30 a.m., Tuesday, June 17, 2025Location: Room 153A, Boston Convention & Exhibition Center To schedule a meeting in advance or during the conference, please contact our BD representatives, Max Wang ( and Liyan Gao ( or visit us at Booth #1851. Meetings can also be requested via the BIO partnering system. About Fapon Biopharma ( Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone. View original content to download multimedia: SOURCE Fapon Biopharma Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
3-vehicle crash on Hwy. 101 blocks traffic during rush hour in SLO
A three-vehicle crash blocked traffic on Highway 101 through San Luis Obispo on Wednesday, slowing the evening commute, the California Highway Patrol said. A gray Toyota Sienna, a black SUV and a blue pickup truck crashed at about 4:52 p.m. on northbound Highway 101 near the Madonna Road off-ramp, the CHP traffic log said. Emergency responders shut down the Nos. 1 and 2 lanes of northbound Highway 101 to respond to the crash. Traffic passed through the area on the off-ramp, the CHP said. The CHP did not know whether the crash resulted in injuries as of 5:15 p.m. A Caltrans highway camera showed traffic slowed to a crawl through the area.
